Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, Mabpharm Ltd increased its cash reserves by 416.40%, or 139.78m. Cash Flow from Financing totalled 85.60m or 98.21% of revenues. In addition the company generated 57.39m in cash from operations while cash used for investing totalled 3.51m.
Cash flow per share | -0.0381 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0307 |
---|---|
Tangible book value per share | 0.0307 |
More ▼
Balance sheet in CNYView more
Current ratio | 1.07 |
---|---|
Quick ratio | 0.6836 |
Total debt/total equity | 2.12 |
---|---|
Total debt/total capital | 0.679 |
More ▼